CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Immunology: Which Cells Have a Lymphoid Lineage and How Are They Identified?

Read More
All Posts

In humans, hematopoietic stem cells (HSCs) continuously replenish all types of blood cells via a series of lineage restriction steps. This process begins with the production of common lymphoid progenitor (CLP) and common myeloid progenitor (CMP) cells, which subsequently differentiate further in response to various stimuli.

Cells of the lymphoid lineage include T and B cells, which are involved in adaptive immunity, and natural killer (NK) cells, which are part of the innate immune system.

Blog: Which Cells Have a Lymphoid Lineage and How Are They Identified?

To understand how different lymphoid lineage cells function in conditions of health and disease, researchers must detect and quantify distinct cellular subtypes within a heterogeneous population. This can be achieved using antibodies for cell type-specific markers, allowing cells of interest to be visualized using techniques such as flow cytometry or immunohistochemistry (IHC). Common marker classes include cluster of differentiation (CD) molecules, transcription factors, and chemokine receptors.

Lymphoid lineage

Terminally differentiated cells of the lymphoid lineage perform diverse roles in the immune response:

  • Cytotoxic T cells kill infected or malignant cells through the release of lytic granules following recognition of their specific antigen by the T cell receptor (TCR); they are capable of forming long-lived memory cells
  • Helper T (Th) cells are also activated by antigen recognition through the TCR and coordinate immune responses by influencing the function of other cells through cytokine secretion and immunomodulatory receptors expressed on the cell surface; they can form long-lived memory cells
  • B cells are antibody-expressing cells that undergo rapid clonal expansion upon encountering their target antigen to form short-lived plasma cells and lasting memory B cells
  • NK cells kill infected and malignant cells; their cytotoxic activity is controlled by the balance of signals received from activating receptors that bind ligands expressed by infected or transformed cells and inhibitory receptors that bind MHC I molecules

Lymphoid Lineage Cell Types

Although broad subsets of lymphoid lineage cells can be characterized using just one or two markers, identifying specific cell types within each subset often involves detecting defined marker groups. For example, all T cells express CD3, but upon differentiation into cytotoxic T cells and T helper cells, these cell types express CD8 and CD4, respectively. T helper cells are sub-categorized based on the presence of additional markers, with Th1 cells being identified by expression of T-Bet and IFNγ, Th2 cells staining positive for GATA-3 and IL-4, and Th17 cells expressing both RORγt and IL-17. Other major T helper cell subtypes include regulatory T cells (Tregs) that are characterized by expression of FoxP3 and CD25, and T follicular helper cells (Tfhs) that express Bcl-6, CXCR5, and IL-21.

Like T cells, B cells can be identified using just a single marker, in this case CD19. However, distinguishing between naïve B cells, plasma cells, and memory B cells again involves detecting different marker combinations. While naïve B cells are positive for IgD and negative for CD27, plasma cells are characterized using either BCMA or CD138. Memory B cells exhibit differential expression of IgD and CD27 depending on whether they have undergone class-switching (IgD- CD27+), or not (IgD+ CD27+). Like memory B cells, NK cells display differential marker expression according to cell function.

To see key cell and functional state markers for immune cells, optimized for flow cytometry and IHC, download the immune cell markers guide:

 

Immune Cell Marker Pathway

 

Recent Posts

500 Antibodies & Counting: Accelerating Discovery with CST Antibodies Validated for Simple Western Technology

Since 2022, Cell Signaling Technology (CST) and Bio-Techne have been working together to bring best-in-cl...
Chris LaBreck, PhD Oct 23, 2024

Menin-KMT2A Inhibitors: A Promising Approach to Acute Myeloid Leukemia (AML) Treatment

Accounting for about 80% of adult acute leukemias, acute myeloid leukemia (AML) is an aggressive form of ...
Homa Rahnamoun, PhD Oct 16, 2024

CST Turns 25: Celebrating a Quarter Century of Antibodies & Innovations

This year, CST turns 25. As we celebrate this significant milestone, we’re also reflecting on how the res...
Alexandra Foley Sep 24, 2024